Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma : why clinical trials might have failed and how they could succeed
MetadataShow full item record
Meemanage , M , Spender , L C , Collinson , D , Iannetta , J , Challapalli , P , Turbitt , J , Clark , C , Baxter , M , Murray , G , Walsh , S , Miedzybrodzka , Z & Petty , R D 2021 , ' Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma : why clinical trials might have failed and how they could succeed ' , Cancer Chemotherapy and Pharmacology , vol. 87 , pp. 361–377 . https://doi.org/10.1007/s00280-020-04187-w
This article is licensed under a Creative Commons Attri- bution 4.0 International License, which permits use, sharing, adapta- tion, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.